$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
Analysis of the efficacy and role of Osimertinib (Tagrisso) and actual patient feedback
2026-02-01 22:25:32
Check Details
Efficacy and possible side effects of Eltrombopag (Revlan)
2026-02-01 22:25:32
Check Details
Can Roprostim (Wilgen) cure specific types of thrombocytopenia?
2026-02-01 22:25:32
Check Details
The use of Midostaurin in special groups such as the elderly or patients with abnormal liver and kidney function
2026-02-01 22:25:32
Check Details
Can Cabergoline shrink pituitary tumors and observe its efficacy
2026-02-01 22:25:32
Check Details
How long does the course of Momelotinib (Momelotinib) treatment for blood diseases usually last?
2026-02-01 22:25:32
Check Details
Causes and countermeasures for dizziness after taking Biken Pronol Tablets (Bituvi)
2026-02-01 22:25:32
Check Details
The therapeutic effect of decavatinib on psoriasis and patient feedback
2026-02-01 22:25:32
Check Details
What is the safest and most effective way to take a missed dose of Apremilast (Otelor)?
2026-02-01 22:25:32
Check Details
When is the best time to take Valganciclovir before or after meals?
2026-02-01 22:25:32
Check Details
Analysis of instructions for usage, dosage and precautions of voclosporin
2026-02-01 22:25:32
Check Details
How long can I usually take ponatinib? Long-term medication management and treatment course observation and analysis summary
2026-02-01 22:25:32
Check Details
1
2
...
2271
2272
2273
2274
2275
2276
2277
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma